Methods of using select Schiff base compounds for chemical agent detoxification

Abstract

A method of using select Schiff base compounds for chemical agent detoxification. The method including applying a compound to the contaminated substrate. The compound includes an imine having at least one Schiff base nitrogen and an alkyl substituent or an aryl substituent having an electron acceptor. The at least one Schiff base nitrogen is spaced away from the electron acceptor by a distance ranging from about 200 pm to about 1000 pm. The substrate and the compound are dried. The at least one Schiff base nitrogen of the compound promotes a nucleophilic attack on an electrophilic site of the toxic chemical agent.

Claims

1. A method of detoxifying a substrate contaminated with a toxic chemical agent, the method comprising: applying a composition to the contaminated substrate, the composition comprising 8-hydroxyquinoline or 1,2-benzisothiazol-3(2H)-one; and drying the substrate with the composition.

2. The method of 1, wherein the toxic chemical agent is a nerve chemical warfare agent or a blister chemical warfare agent.

3. The method of claim 1, wherein drying the substrate with the composition includes applying an electromagnetic radiation, applying irradiative heat, changing pH, or combinations thereof.

4. The method of claim 1, wherein a quantity of the composition does not exceed 20 wt. %.

5. The method of claim 1, wherein applying the composition further comprises: cross-linking the composition to the substrate with a cross-linking agent that selected from the group consisting of a siloxane, an acrylate, and epoxide, and combinations thereof.

6. A method of preparing a detoxifying substrate, the method comprising: selecting a first composition based on a first expected toxic chemical agent exposure, the first composition comprising 8-hydroxyquinoline or 1,2-benzisothiazol-3(2H)-one; applying a quantity of the first selected composition to the substrate; and optionally drying the substrate.

7. The method of claim 6, further comprising: selecting a second composition based on a second expected chemical agent exposure, the second composition comprising 8-hydroxyquinoline or 1,2-benzisothiazol-3(2H)-one; applying a quantity of the second selected composition to the substrate; and optionally drying the substrate.

8. The method of claim 7, wherein a combined quantity of the first composition and the second composition does not exceed 20 wt. %.

9. The method of claim 6, wherein drying the substrate includes applying an electromagnetic radiation, applying irradiative heat, changing pH, or combinations thereof.

10. A method of pretreating a substrate to resist toxic chemical agent contamination, the method comprising: applying a composition to the substrate, the composition comprising 8-hydroxyquinoline or 1,2-benzisothiazol-3(2H)-one; drying the substrate with the composition; and exposing the pretreated substrate to a toxic chemical agent.

11. The method of 10, wherein the toxic chemical agent is a nerve chemical warfare agent or a blister chemical warfare agent.

12. The method of claim 10, wherein drying the substrate with the composition includes applying an electromagnetic radiation, applying irradiative heat, changing pH, or combinations thereof.

13. The method of claim 10, wherein a quantity of the composition does not exceed 20 wt. %.

14. The method of claim 10, wherein applying the composition further comprises: cross-linking the composition to the substrate with a cross-linking agent that selected from the group consisting of a siloxane, an acrylate, and epoxide, and combinations thereof.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the present invention and, together with a general description of the invention given above, and the detailed description of the embodiments given below, serve to explain the principles of the present invention.

(2) FIGS. 1A and 1B are representations of pretreatment chemicals according to embodiments of the present invention.

(3) FIG. 2 is a representation of a chemical mechanism by which pretreatment chemicals according to embodiments of the present invention may neutralize sarin, a neurotoxic agent.

(4) FIGS. 3A and 4A are representations of pretreatment chemicals according to other embodiments of the present invention.

(5) FIGS. 3B and 4B are representations of resonance tautomers of the pretreatment chemicals of FIGS. 3A and 4A, respectively.

(6) FIG. 5 is a flowchart illustrating a method of treating a substrate with a pretreatment chemical according to one embodiment of the present invention.

(7) FIG. 6 is a graphical representation of data obtained from a 80 g/cm.sup.2 challenge of DFP vapor against cotton fabric samples treated with 8-hydroxyquinoline and 1,2-benzisothiazol-3(2H)-one.

(8) FIG. 7 is a graphical representation of DFP performance against control samples and cotton fabric samples treated with 8-hydroxyquinoline and 1,2-benzisothiazol-3(2H)-one.

(9) FIG. 8 is a graphical representation of an 80 g/cm.sup.2 challenge of DFP vapor against cotton fabric samples treated with 8-hydroxyquinoline and 1,2-benzisothiazol-3(2H)-one.

(10) FIG. 9 illustrates three .sup.31P NMR spectra of a challenge of DFP vapor against cotton fabric samples treated with pretreatment chemicals according to embodiments of the present invention.

(11) It should be understood that the appended drawings are not necessarily to scale, presenting a somewhat simplified representation of various features illustrative of the basic principles of the invention. The specific design features of the sequence of operations as disclosed herein, including, for example, specific dimensions, orientations, locations, and shapes of various illustrated components, will be determined in part by the particular intended application and use environment. Certain features of the illustrated embodiments have been enlarged or distorted relative to others to facilitate visualization and clear understanding. In particular, thin features may be thickened, for example, for clarity or illustration.

DETAILED DESCRIPTION OF THE INVENTION

(12) The present invention relates to compounds for chemical agent detoxification and methods of applying the compounds to substrates for detoxification thereof or treatment prior to exposure to the chemical agent.

(13) As used herein, alkyl means a branched or unbranched, alkane or alkene substituent consisting of carbon and hydrogen, for example, methyl, ethyl, propyl, isopropyl, 1-butyl, 2-butyl, isobutyl, tert-butyl, pentyl, 2-methylbutyl, 1,1-dimethylpropyl, hexyl, heptyl, octyl, nonyl, and decyl.

(14) As used herein, aryl means a cyclic, aromatic substituent consisting of hydrogen and carbon, for example, phenyl, naphthyl, and biphenylyl.

(15) As used herein, Schiff base nitrogen is defined as the nitrogen atom of a carbon-nitrogen double bond, wherein the nitrogen atom is chemically bonded to the alkyl or aryl and not to a hydrogen atom.

(16) As used herein, substituted is defined by the substitution of a hydrogen on a carbon by a univalent group including, but not limited to, halogen, hydroxy, thiol, amino, nitro, cyano, C1-C4 alkyl, alkylamino, carboxy, amido, vinyl, and C1-C5 alkoxy.

(17) Lewis acid, as used herein, is defined as a chemical substance that can employ an electron lone pair from another molecule.

(18) Lewis base, as used herein, is defined as any chemical substance that donates a pair of electrons to a Lewis acid.

(19) Tautomers, as used herein, are structural isomers of organic compounds that are in dynamic equilibrium due to the migration of a proton.

(20) Referring now to the figures, and in particular to FIGS. 1A and 1B, pretreatment chemicals 10, 12 according to embodiments of the present invention are shown, wherein each of R, .sup.1R1, and .sub.2R is an alkyl substituent or an aryl substituent. Generally, the pretreatment chemicals 10, 12 comprise an imine (e.g., a Lewis base) and an alkyl substituent or an aryl substituent and are configured to detoxify a chemical agent having at least one leaving group. A Schiff base nitrogen 14, 16 of the imine is separated from an electron acceptor (for example, acidic proton 18) by a distance, d, that ranges from about 2 bond length radii to about 10 bond length radii (that is, from about 200 pm to about 1000 pm) as determined, for example, by molecular mechanics (MM+) geometry optimization (conjugate gradient; RMS gradient 0.0001 kcal/.Math.mol).

(21) If desired, the pretreatment chemical may further comprise a cross-linking agent that is configured to form a cross-linkage chemical bond between the pretreatment chemical and a substrate.

(22) It will be readily appreciated by the skilled artisan that the pretreatment chemical 12 illustrated in FIG. 1B is shown as a thermodynamic minimum representation, that is, as a canonical resonance form.

(23) According to another embodiment of the present invention, a pretreatment chemical comprises a catalyst configured to react with Lewis acids, the catalyst having an electron acceptor (for example, an acidic proton) spaced away from a Schiff base nitrogen by a distance that ranges from about 200 pm to about 1000 pm (or from about 2 bond length radii to about 10 bond length radii). More specifically the catalysts are configured to react with and detoxify toxic pesticides and potent nerve agents, including, for example, phosphoric acid esters (sarin, soman, VX, diisopropyl fluorophosphates, etc.), and blister agents, (such as bis(2-chloroethyl) sulfide) having at least one leaving group. Examples of leaving groups may include, but are not limited to, one or more halide ions, thiolates, amines, alcohols, perfluoroalkylsulfonates, tosylates, and cyanide. The remaining electrophile may contain phosphorus, sulfur, arsenic, or nitrogen.

(24) While not wishing to be bound by theory, it is believed that, for example, phosphoric acid esters may be decontaminated with the pretreatment chemicals of the present invention in accordance with the mechanism illustrated in FIG. 2. More particularly, FIG. 2 illustrates a reaction between sarin 20 ([(CH.sub.3).sub.2CHO]CH.sub.3P(O)F), an organophosphorus compound used in chemical warfare as an extremely potent nerve agent, and 8-hydroxyquinoline 22 (hereafter, 8-HQ), a pretreatment chemical according to one embodiment of the present invention. 8-HQ 22 is a known antiseptic approved for multiple uses by the USDA. As shown, the imine group of 8-HQ 22 serves as a Lewis base that attacks the phosphorous center of the sarin 20 (i.e., a Lewis acid). The attack leads to a subsequent loss of HF from the system. The 8-HQ 22 activity may be regenerated by reacting with a water molecule 24, which donates a proton to the phenolate ion. 8-HQ 22 is regenerated in the presence of water by hydrolytic attack of the phosphorus atom of the 8-HQ-agent adduct, followed by release of a neutralized phosphonic acid product 26.

(25) A similar mechanism, although not shown, is expected for an opthamolic drug, diisopropyl fluorophosphates (a cholinergic molecule), and the nerve agent, soman (0-pinacolyl methylphosphonofluoridate).

(26) Mustard compounds, such as 2-chloroethyl ethyl sulfide and bis(2-chlorethyl)sulfide, are also expected to follow a similar mechanism. That is, a lone pair of electrons from the Schiff base nitrogen serves as the Lewis base and attacks the #2 carbon bonded to the chlorine or the carbon bonded to sulfur in the episulfonium configuration. In concerted fashion, the chlorine picks up the local acidic hydrogen. In the presence of water, the phenolate ion from 8-HQ regains a proton from a local water molecule, and the remaining hydroxide allows regeneration of the catalyst to form from the water. Such a mechanism results in either elimination to form a vinyl product (anhydrous), or, in the presence of water, substitution to form thiodiglycol or 1,4-oxathiane, all of which are acceptably nontoxic decontamination products.

(27) A similar mechanism is also expected for treatments against toxic industrial chemicals, such as acrolein (CH.sub.2CHCHO), that is, through a catalytic reduction to 2-propen-1-ol in the presence of atmospheric water vapor.

(28) FIGS. 3A and 4A are representations of pretreatment chemicals according to still other embodiments of the present invention. Particularly, FIG. 3A is 8-HQ and FIG. 4A is 1,2-benzisothiazol-3(2H)-one (hereafter, BIT), which is commercially-available under the tradename BIOBAN from Dow Corning and is described in detail in U.S. Application Publication No. 2010/0125095, entitled BIOCIDAL COMPOSITION OF 2,6-DIMETHYL-M-DIOXANE-4-OL ACETATE AND METHODS OF USE, as an anti-fouling additive for coatings. BIT is approved for use in Asia and is expected to be approved for use in the US in the near future.

(29) Resonance tautomers of 8-HQ and BIT are shown in FIGS. 3B and 4B, respectively.

(30) With reference now to FIG. 5, a flowchart 30 illustrating a method of using a pretreatment chemical according to one embodiment of the present invention is shown. In Block 32, a pretreatment chemical according to one embodiment of the present invention is selected, wherein the selection is based, at least in part, on an anticipated agent exposure. For example, the anticipated agent may be any environmental toxin, chemical warfare agent, pesticide, industrial chemical, and so forth. Section of the pretreatment chemical may also be based on the known chemical structure of the anticipated agent such that the pretreatment chemical may under an appropriate detoxification mechanism, similar to those described above.

(31) With the pretreatment chemical selected, a quantity of the selected pretreatment is applied to a substrate (Block 34). The substrate, while referenced here as being a fabric or textile, may include any suitable coating, textile (woven and nonwovens), plastic, metal, ceramic, polymer, and so forth. Application of the pretreatment chemical may be direct, that is, without dilution, or by dissolving or suspending a quantity of the pretreatment chemical in an organic or aqueous solvent (for example, a 0.1%-30% solution) that is then applied to the substrate. In any event, the pretreatment chemical may bind to (for example, via cross-linking) or otherwise be retained by (for example, via intercalation) a material comprising the substrate. With respect to cross-linking, the pretreatment chemical may include conventional cross-linking chemistries including, for example, siloxanes, acrylates, radical polymerization, epoxides, and so forth. Generally, application of the pretreatment chemical may range from about 0.1 wt. % to about 5.0 wt. %.

(32) If desired or necessary, the substrate may optionally be dried (Block 36). Drying may additionally or alternatively include heating, for example, in an oven (such as with exemplary temperatures ranging from about 75 C. to about 200 C.) or microwave. However, drying at temperatures above about 200 C. may damage textile fibers, melt polyolefins, or both. Cross-linking by drying may include an initiator, which may be a chemical initiator, light, or other forms of electromagnetic radiation. According to some embodiments including siloxanes, cross-linking may also occur with changes in pH.

(33) It will be readily appreciated by those of ordinary skill in the art having the benefit of the disclosure provided herein that a plurality of pretreatment chemicals according to various embodiments of the present invention may be applied to the same substrate. In that regard, applications of pretreatment chemicals may be simultaneous or sequential. As shown in FIG. 5, and when an additional treatment is desired (Yes branch of Decision Block 38), then the process returns and a pretreatment chemical according to another embodiment of the present invention is selected (Block 32). Otherwise, (No, branch of Decision Block 38), the process continues. Accordingly, resultant coatings may comprise a combination of pretreatment chemicals, such as 2.5% BIT and 2.5% 8-HQ; however, other combinations are also envisioned within the scope of this disclosure.

(34) It would also be appreciated that the pretreatment chemical may be applied to substrate prior to or after manipulation of the substrate. For example, fabric comprising a garment may be treated prior to or after garment construction. Therefore, the treated substrate may optionally be used to construct a product, for example, a garment or headgear, or activated carbon, carbon beads, or carbon cloth (Block 40). Otherwise, although not specifically shown in FIG. 5, the substrate may be manipulated prior selection of the pretreatment chemical.

(35) According to still other embodiments of the present invention, the substrate may be treated after exposure to an agent. In that regard, the treatment may be for purposes of remediation, demilitarization, or detoxification rather than protection or prevention.

(36) The following examples illustrate particular properties and advantages of some of the embodiments of the present invention. Furthermore, these are examples of reduction to practice of the present invention and confirmation that the principles described in the present invention are therefore valid but should not be construed as in any way limiting the scope of the invention.

Example 1

(37) Textile surfaces were treated with a solution comprising 1.75% w/v of 8-HQ and 1.75% BIT, or their derivatives, in 80 mL of acetone. In a separate solution, 4 mL of tetramethyl orthosilicate and 10 mL of 0.1 M hydrochloric acid are combined and vortexed for 1 min. The tetramethyl orthosilicate solution was then added to the acetone solution, mixed thoroughly, vortexed, and applied to the dry textile surface. The treated textile surface was heated until cured, such as by either conventional heating at 75 C. or microwave for 45 sec.

Example 2

(38) Pretreatment chemicals according to embodiments of the present invention were applied to paints and coatings by replacing the pigment component of the paint or coating with a volume of the pretreatment chemical (ranging from 1% w/w to 10% w/w). The paints and coatings were applied to surfaces according to convention methods. Hazardous materials were deactivated when placed in contact with surfaces treated with the paints or coatings.

Example 3

(39) Cotton samples treated with 8-HQ and BIT were challenged in a headspace permeation experiment against a sarin stimulant, 5 g of diisopropylfluorophosphate (DFP) vapor, as an 80 g/cm.sup.2 total challenge. In FIG. 6, SBC Treatment A is shown to outperform the SBC control, particularly over the first several hours.

(40) Table 1, below, provides specific data values shown in FIG. 6. At 15 min, the treated cotton samples offer full vapor protection from DFP. After 60 min, the treatment reduces the contaminant breakthrough by roughly 2.5-log, and at 120 min the treatment still mitigates the challenge by about two-orders of magnitude.

(41) TABLE-US-00001 TABLE 1 Time (min) 15 60 120 270 1320 SBC 1.35E+09 2.97E+09 2.49E+09 1.83E+09 2.42E+08 (+/) 9.32E+08 1.65E+08 6.56E+07 1.36E+08 6.52E+07 SBC 0.00E+00 6.46E+06 2.09E+07 4.39E+07 3.45E+07 Treatment A (+/) 0.00E+00 1.59E+06 4.98E+06 1.12E+07 8.00E+06

Example 4

(42) Cotton samples were treated with different combinations of 8-HQ/BIT and challenged for 2 hr with 5 g DFP vapor in a headspace permeation experiment. In FIG. 7, all combinations of 8-HQ/BIT are shown to mitigate the DFP challenge with respect to the controls. Tetramethyl orthosilicate (TMOS), used herein as a cross-linker to attach catalysts to the cotton samples, was also included as a negative control.

Example 5

(43) FIG. 8 is a graphical representation of the same 8-HQ/BIT combination material as Example 4 but against sulfur mustard, bis(2-chloroethyl) sulfide (HD). Table 2, below, provides specific data values from FIG. 8. While these results are not as dramatic as those demonstrated with DFP in FIG. 7, there was still a 25% to 92% reduction of the mustard challenge at different points during a 24 hr span.

(44) TABLE-US-00002 TABLE 2 Time (min) 60 120 270 1410 SBC 2.83E+09 2.05E+09 1.35E+09 8.13E+07 SBC Treatment A 1.88E+09 1.58E+09 1.05E+09 3.02E+07 % diff [HD] 40 26 25 92

Example 6

(45) FIG. 9 includes .sup.31P NMR data, obtained from the U.S. Army Natick Soldier Research Development & Engineering Center (Natick, Mass.) for the decomposition of DFP in the presence of the three different pretreatment chemical formulations according to embodiments of the present invention (shown below in Table 3). The presence of the phosphonic acid decomposition product 26 (FIG. 2) at 3 ppm (FIG. 9) is clearly visible, particularly in the third sample, C, containing 2.5% 8-HQ and BIT, after about 10 min of exposure. The differences in chemical shift are thought to occur by perturbation of the magnetic field due to the incorporation of SiNPs.

(46) TABLE-US-00003 TABLE 3 Fabric Composition A 2.5% 8-HQ B 2.5% 8-HQ and Fluorinated Silane C 2.5% 8-HQ, BIT, SiNP, and Fluorinated Silane

Example 7

(47) 8-HQ treated fabric and controls were tested against a 400 g/cm.sup.2 sample of soman for 5 days. Permeation data, acquired at the Army Edgewood Chemical and Biological Center (Edgewood, Md.), are shown in Table 4, below. Treated fabrics outperformed the controls against the soman agent by approximately 100-fold, which was observable for up to 5 days (arbitrary units).

(48) TABLE-US-00004 TABLE 4 Control Control 8-HQ 8-HQ 8-HQ Average Time Sample Sample Sample Sample Sample (8HQ/ (days) 1 2 1 2 3 Control) 1 7.7 5.4 ND ND ND N/A 5 42.6 35.4 0.6 0.37 0.34 1.12%

(49) Table 5 includes data, similar to Table 4, but against a 400 g/cm.sup.2 sample of sulfur mustard agent for 3 days. Treated fabrics outperformed the controls against the sulfur mustard agent by approximately 10-fold, which was observed for up to 3 days (arbitrary units).

(50) TABLE-US-00005 TABLE 5 Control Control 8-HQ 8-HQ 8-HQ Average Time Sample Sample Sample Sample Sample (8HQ/ (hr) 1 2 1 2 3 Control) 8 152.4 155.5 18.4 15.6 16.1 10.7% 72 27.86 39.02 0.97 0.74 0.96 2.6%

(51) Table 6 includes data, similar to Tables 4 and 5, but against a 400 g/cm.sup.2 sample of DFP for 2 days. Treated fabrics outperformed the controls against the DFP agent by approximately 10-20-fold, which was observed for up to 2 days (arbitrary units).

(52) TABLE-US-00006 TABLE 6 Control Control 8-HQ 8-HQ 8-HQ Average Time Sample Sample Sample Sample Sample (8HQ/ (hr) 1 2 1 2 3 Control) 8 190.9 157.5 19.1 15.6 24.8 11.3% 72 244.2 256.8 14.22 12.6 16.1 5.6% 48 185.2 245.1 2.8 2.8 3.8 1.4%

(53) Table 7 summarized direct liquid deposition testing on the fabrics tested in this Example 7. Treated fabrics performed significantly better than controls against all three agents (arbitrary units).

(54) TABLE-US-00007 TABLE 7 8-HQ 8-HQ Average Agent Control Sample 1 Sample 2 (8HQ/Control) Soman 469.2 0.94 0.4 0.14% Sulfur Mustard 4164 54.3 76.4 1.57% DFP 1543 11.9 8.3 0.65%

(55) While the present invention has been illustrated by a description of one or more embodiments thereof and while these embodiments have been described in considerable detail, they are not intended to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications will readily appear to those skilled in the art. The invention in its broader aspects is therefore not limited to the specific details, representative apparatus and method, and illustrative examples shown and described. Accordingly, departures may be made from such details without departing from the scope of the general inventive concept.